Meningioma

Meningioma is a type of tumor that grows from the meninges, the three layers of tissue that wrap and protect the brain and spinal cord. Some tumors are benign and don’t need immediate treatment. But some meningiomas are atypical, meaning the cells act more aggressively, grow more quickly, and require treatment. Our neurosurgeons, neurologists, and radiation oncologists work together to assess the growth and appearance of these tumors and create a personalized treatment plan for you.

Clinical Trials and Research Studies

Phase 1

A Phase I/II Study of Nivolumab plus or minus Ipilimumab in Combination with Multi-fraction Stereotactic Radiosurgery for Recurrent High-grade Radiation-relapsed Meningioma

Learn More

Phase 2

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 (INTUITT-NF2)

Learn More

Phase 2

A Phase 2 Study of the PARP Inhibitor Olaparib (AZD2281) in IDH1 and IDH2 mutant Advanced Solid Tumors

Learn More

Phase 3

A Phase 3 Randomized Non-Inferiority Study of Carboplatin and Vincristine versus Selumetinib (NSC# 748727 IND# 77782) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1(NF1)

Learn More